Use the Search Fields to Find Information
Page 75 of 382
Role of cannabinoids in pain management
Cannabinoids are pharmacological agents of endogenous (endocannabinoids), botanical (phytocannabinoids), or synthetic origin; Cannabinoids alleviate pain through a variety ofreceptor and non-receptor mechanisms including direct analgesic
September 19, 2019
Role of Cannabinoids in Gastrointestinal Mucosal Defense and Inflammation
Modulating the activity of the endocannabinoid system influences various gastrointestinal physiological and pathophysiological processes, and cannabinoid receptors as well as regulatory enzymes responsible for the
September 16, 2020
Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
Abstract Drug treatments available for the management of substance use disorders (SUD) present multiple limitations in efficacy, lack of approved treatments or alarming relapse rates.
April 16, 2024
Role of Cannabidiol for Improvement of the Quality of Life in Cancer Patients: Potential and Challenges
Abstract There is currently a growing interest in the use of cannabidiol (CBD) to alleviate the symptoms caused by cancer, including pain, sleep disruption, and
January 18, 2024
Role of Cannabidiol and Tetrahydrocannabivarin on Paclitaxel-induced neuropathic pain in rodents
Please use this link to access this publication Abstract The purpose of this study was to evaluate if phytocannabinoids, synthetic cannabidiol (CBD), and tetrahydrocannabivarin (THCV),
January 31, 2024
Role of 5HT1A Receptors in the Neuroprotective and Behavioral Effects of Cannabidiol in Hypoxic–Ischemic Newborn Piglets
Abstract Background: Hypoxic–ischemic (HI) insults have important deleterious consequences in newborns, including short-term morbidity with neuromotor and cognitive disturbances. Cannabidiol (CBD) has demonstrated robust neuroprotective
January 30, 2024
Risks of Cannabinoid Exposure on Birth Outcomes: A Systematic Review
Abstract Introduction: With the changing legal landscape, the acceptance and availability of cannabis products have increased. Cannabis products are generally considered “natural” and relatively safe
March 7, 2026
Risk-thresholds for the association between frequency of cannabis use and the development of psychosis: a systematic review and meta-analysis
Abstract BackgroundEpidemiological studies show a dose–response association between cannabis use and the risk of psychosis. This review aimed to determine whether there are identifiable risk-thresholds
February 29, 2024
Risk thresholds for the frequency of cannabis use during pregnancy and adverse neonatal outcomes: protocol for a systematic review and dose-response meta-analysis
Abstract Background Cannabis use during pregnancy has been increasing and is associated with adverse neonatal outcomes, such as low birth weight (LBW) and preterm birth (PTB).
December 7, 2025
Risk Factors for Cannabis-Related Mental Health Harms in Older Adults: A Review
Please use this link to access this publication. ABSTRACT Objectives: This paper reviews research on the topic of cannabis use and mental health harms in older
October 13, 2025
Page 75 of 382